Nafa Asset Managers Private Limited • Equity
NAFA Pharma Portfolio is an equity portfolio management service (PMS) strategy run by Nafa Asset Managers Private Limited, launched on 24 Aug 2020. As of 30 Sep 2026, it is benchmarked against the BSE 500 TRI. Its reported trailing returns are -7.29% over 5 years (-0.91% since inception). The minimum investment is ₹50 Lakhs. The strategy is managed by NARAYANAN BALAJI VAIDYANATH.
Returns and AUM as of , as reported to APMI. Last checked . Source: public PMS performance disclosures. Returns are as reported by the portfolio manager; past performance is not a guarantee of future returns.
| Period | Return |
|---|---|
| 5 Years | -7.29% |
| Since Inception | -0.91% |
| management fee | Fixed Fees: Up to 2.5% per annum |
| performance fee | Variable Fees: NIL |
| exit load | 1% for 2years since inceptions |
A PMS needs at least ₹50 lakh. Before you commit, get a second opinion on fees, benchmark and fit from Foliyo, a fee-only SEBI Registered Investment Adviser.
Book an intro callNAFA Pharma Portfolio has a 5-year return of -7.29% and -0.91% since inception as of 30 Sep 2026. Past performance is not indicative of future results.
Over 5 years, NAFA Pharma Portfolio returned -7.29% against +8.91% for the BSE 500 TRI, 16.20 percentage points behind. Figures as of 30 Sep 2026.
NAFA Pharma Portfolio is managed by NARAYANAN BALAJI VAIDYANATH at Nafa Asset Managers.
The fee structure for NAFA Pharma Portfolio includes: management fee: Fixed Fees: Up to 2.5% per annum; performance fee: Variable Fees: NIL; exit load: 1% for 2years since inceptions.
The minimum investment for NAFA Pharma Portfolio is ₹50 Lakhs.
NAFA Pharma Portfolio was launched on 24 Aug 2020. It has a 6-year track record.
Description
All Nafa Asset Managers PMS strategies →Browse all PMS strategies in India →